Intrathecal Drug Delivery
José De Andrés1,2, Rubén Rubio-Haro3, Carmen De Andres-Serrano4
1Unit of Anesthesia, Department of Surgical Specialties, Valencia University Medical School, Valencia, Spain. deandres_jos@gva.es.
Methods in Molecular Biology (Clifton, N.J.)
|August 23, 2019
Summary
Intrathecal drug delivery systems (IDDS) offer safe, effective management for chronic pain and spasticity. Staying updated on IDDS technology and pharmacology is crucial for optimizing patient outcomes.
Area of Science:
- Neurology
- Pain Management
- Neurosurgery
Background:
- Intrathecal drug delivery systems (IDDS) are established treatments for chronic pain and spasticity.
- While generally safe, IDDS therapy carries risks and requires management at specialized centers.
- Technological advancements and new applications necessitate updated recommendations for IDDS.
Purpose of the Study:
- To review technological aspects of intrathecal drug delivery systems (IDDS) implantation and follow-up.
- To provide updated pharmacological recommendations for IDDS in managing chronic pain and spasticity.
- To support evidence-based decision-making for optimizing IDDS therapy outcomes.
Main Methods:
- Review of recent technological advancements in IDDS.
- Analysis of current pharmacological strategies for intrathecal drug administration.
- Examination of reported complications and maintenance requirements for IDDS.
- Synthesis of evidence-based recommendations for IDDS management.
Main Results:
- IDDS are effective for chronic nonmalignant/malignant pain and severe spasticity.
- Risk-benefit ratio favors IDDS, but specialized management is essential.
- Recent literature provides updated guidance on IDDS technology, pharmacology, and complication management.
Conclusions:
- Continuous updates on IDDS technology and pharmacology are vital for effective patient care.
- Evidence-based recommendations improve decision-making in managing chronic pain and spasticity with IDDS.
- Specialized centers are crucial for safe and optimal management of intrathecal drug delivery systems.
Related Concept Videos
01:16Drug Delivery: Overview
748
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
748
01:18Drug Delivery: Enteral Route
1.6K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.6K
01:29Drug Delivery: Parenteral Route
1.6K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.6K
01:22Drug Delivery: Miscellaneous Routes
726
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
726
01:25Pharmacokinetics: Drug–Drug Interactions
376
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
376
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
152
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
152